The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-Based Case Report

The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-Based Case Report

Show other versions (1)

Aim: to know the effectiveness of probiotic in reducing hepatic inflammation among non-alcoholic fatty liver disease (NAFLD) patients. Methods: we performed literature searching regarding the potential role of probiotic in reducing hepatic inflammation among NAFLD patients. Results: six articles wer...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alvin Nursalim, Ummi Ulfah Madina, Cosmas Rinaldi A Lesmana
Format:	Article
Language:	English
Published:	Interna Publishing 2017-02-01
Series:	Acta Medica Indonesiana
Subjects:	non-alcoholic fatty liver disease NAFLD probiotic inflammation
Online Access:	https://www.actamedindones.org/index.php/ijim/article/view/265
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-Based Case Report
by: Alvin Nursalim, et al.
Published: (2017-02-01)

Evaluating Pediatric NAFLD with Controlled Attenuation Parameter: A Comprehensive Narrative Review
by: Ingrid Arteaga, et al.
Published: (2025-01-01)

Correction of liver changes caused by alcohol rates with probiotics
by: Zhadyra Orynbayeva, et al.
Published: (2024-10-01)

Therapeutic Targets and Approaches to Manage Inflammation of NAFLD
by: Wanying Geng, et al.
Published: (2025-02-01)

Limosilactobacillus mucosae FZJTZ26M3 prevents NAFLD in mice through modulation of lipid metabolism and gut microbiota dysbiosis
by: Danting Dang, et al.
Published: (2024-05-01)

Exercise ameliorates hepatic lipid accumulation via upregulating serum PRL and activating hepatic PRLR-mediated JAK2/STAT5 signaling pathway in NAFLD mice
by: Jia Fan, et al.
Published: (2025-08-01)

A Metabolomics-Based Approach for Diagnosing NAFLD and Identifying Its Pre-Condition Along the Potential Disease Spectrum
by: Masanori Nojima, et al.
Published: (2025-03-01)

Adherence to plant based diets reduce the risk of hepatic fibrosis in nonalcoholic fatty liver disease
by: Mahsa Miryan, et al.
Published: (2025-05-01)

Pre-diabetes and cardiovascular risk factors in NAFLD patients: a retrospective comparative analysis
by: Azam Teimouri, et al.
Published: (2025-02-01)

Association between NAFLD and liver fibrosis with nutritional risk index based on the NHANES 2017–2018
by: Jieming Jian, et al.
Published: (2025-01-01)

FF Swin-Unet: a strategy for automated segmentation and severity scoring of NAFLD
by: Liting Fan, et al.
Published: (2025-07-01)

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy
by: Siwen Shen, et al.
Published: (2025-07-01)

Review of roles of RNA-binding proteins on NAFLD and the related pharmaceutical measures
by: Changjin Li, et al.
Published: (2025-05-01)

Correlation of Short Chain Fatty Acid (SCFA) Levels with Transient Elastography Values and Controlled Attenuation Parameters in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Desi Astari, et al.
Published: (2025-07-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Transitioning from NAFLD to MAFLD and MASLD: the toxic relationship with alcohol consumption
by: Mubin Ozercan, et al.
Published: (2025-01-01)

Profile of Children With Non-alcoholic Fatty Liver Disease Referred to a Hospital in Iran
by: Amin Ghanbari, et al.
Published: (2024-12-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

The fasting plasma glucose to high-density lipoprotein cholesterol ratio: a novel index for identifying NAFLD
by: Changhui Yu, et al.
Published: (2025-04-01)

A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity
by: Jie Chen, et al.
Published: (2023-10-01)

Non-Alcoholic Fatty Liver Disease and the Risk of Liver Fibrosis in Chronic Hepatitis B Patients
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-09-01)

Integrated profiling of adiponectin and cytokine signaling pathways in high-fat diet-induced MASLD reveals early markers of disease progression
by: Rabia Johnson, et al.
Published: (2025-06-01)

D-Psicose mitigates NAFLD mice induced by a high-fat diet by reducing lipid accumulation, inflammation, and oxidative stress
by: Jiajun Tan, et al.
Published: (2025-05-01)

Association between oxidative stress and liver fibrosis severity in non-alcoholic fatty liver disease: insights from the pro-oxidant antioxidant balance method in a population from Tehran and Mashhad, Iran
by: Hami Ashraf, et al.
Published: (2025-03-01)

The action of Poria cocos polysaccharides against non-alcoholic fatty liver disease: A preliminary study
by: Rui Zhou, et al.
Published: (2025-12-01)

Metabolic Syndrome in Adults with Nonalcoholic Fatty Liver Disease
by: Zhahid Hassan, et al.
Published: (2021-09-01)

Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseKeypoints
by: Robert F. Schwabe, et al.
Published: (2025-08-01)

Triglycerides mediate the relationships of per- and poly-fluoroalkyl substance (PFAS) exposure with nonalcoholic fatty liver disease (NAFLD) risk in US participants
by: Wenying Qiao, et al.
Published: (2025-01-01)

Mediterranean diet improves liver health but does not protect against azoxymethane-induced colon tumorigenesis compared to Western diet in A/J mice
by: Weimin Guo, et al.
Published: (2025-03-01)

Research progress in the role of endo cannabinoid system in liver diseases
by: BIAN Shu, et al.
Published: (2024-10-01)

Association of ultrasound signs of sarcopenia with serum ferritin levels and hepatic indices like NFS and FIB-4 in NAFLD patients
by: Bahar Arasteh, et al.
Published: (2025-04-01)

New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)

Clopidogrel ameliorates high-fat diet-induced hepatic steatosis in mice through activation of the AMPK signaling pathway and beyond
by: Ting Tai, et al.
Published: (2024-10-01)

Dual inhibition of hepatic ACLY and ACSS2: A synergistic approach to combat NAFLD through lipogenesis reduction and mitochondrial enhancement
by: Mengdi Zhang, et al.
Published: (2025-05-01)

The Mediation Role of Insulin Resistance and Chronic Systemic Inflammation in the Association Between Obesity and NAFLD: Two Cross-Sectional and a Mendelian Randomization Study
by: Huang X, et al.
Published: (2025-03-01)

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

Ferroptosis in NAFLD: insights and the therapeutic potential of exercise
by: Chang Li, et al.
Published: (2025-03-01)

Oxidative stress and inflammation in hemodialysis: a comparison of patients with or without advanced nonalcoholic fatty liver disease (NAFLD)
by: Vanja Kalacun, et al.
Published: (2025-12-01)